Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML von O'Brien, Stephen, Cork, Leanne, Bandeira, Valeria, Bescoby, Ruth, Foroni, Letizia, Alaily, Lynn, Osborne, Wendy, Bell-Gorrod, Helen, Latimer, Nicholas, Apperley, Jane, Hedgley, Corinne, Syzdlo, Richard, Byrne, Jennifer, Pocock, Christopher, Ramsahoye, Bernard, Zwingers, Thomas, Wason, James, Copland, Mhairi, Clark, Richard

Volltext